G. Kemp

A prospective evaluation of transvaginal sonography for detection of ovarian disease.

J. Scatarige, D. DiSantis, G. Kemp, 1993, AJR. American journal of roentgenology.

Papillary peritoneal carcinomatosis after prophylactic oophorectomy.

M. Andrews, G. Kemp, J. Hsiu, 1992, Gynecologic oncology.

Tumor Implantation After Diagnostic Laparoscopic Biopsy of Serous Ovarian Tumors of Low Malignant Potential

G. Kemp, F. Given, J. Hsiu, 1986, Obstetrics and gynecology.

Methotrexate in Advanced Endometrial Carcinoma: A Phase II Trial of the Gynecologic Oncology Group

K. Hatch, H. Muss, J. Soper, 1990, American journal of clinical oncology.

500 Amifostine (AMI) selectively protects against cumulative toxicities of cyclophosphamide (C) and cisplatin (P)

P. Schein, W. Oster, D. Belpomme, 1995 .

Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer.

J. Glick, D. Belpomme, P. Rose, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Malignant melanoma presenting as a unilateral ovarian neoplasm.

G. Kemp, F. Given, J. Hsiu, 1986, Gynecologic oncology.

Echinomycin (NSC 526417) in recurrent and metastatic nonsquamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.

H. Muss, P. Hanjani, J. Blessing, 1992, American journal of clinical oncology.

Transitional cell carcinoma of the renal pelvis with ovarian metastasis.

G. Kemp, J. Hsiu, G. Singer, 1991, Gynecologic oncology.

Pseudomyxoma peritonei: treatment with intraperitoneal 5-fluorouracil.

G. Kemp, M. Nasr, F. T. Given, 1993, European journal of gynaecological oncology.